RAPS RAC-GS Dumps in PDF and Online - Page: 4

QUESTION: 16

Company X and Company Y both have products for the treatment of rare genetic diseases. Company X would like to acquire Company Y but does not know enough about Company Y to make an offer.

What is the MOST appropriate approach that Company X should take to acquire more information about Company Y?

Enter into an agreement with Company Y to perform due diligence.
Recruit a professional to gather confidential intelligence on Company Y.
Request the needed information from the Board of Directors of Company Y.
Perform a thorough library search to gather detailed information on Company Y.

Answer(s): A

Reveal Solution Next Question

QUESTION: 17

After submission to the regulatory authority, a substantial error was found in the application. In order to resolve this issue, what should be done FIRST?

Resubmit the entire package.
Inform upper management immediately.
Contact the legal department and ask them how to proceed.
Verify the procedure in the regulation for the corrections.

Answer(s): D

Reveal Solution Next Question

QUESTION: 18

A company is developing a new product for the global market. A new international guideline will recommend relevant studies in the pediatric population, and the guideline will be effective before the approval of the company's new product.
What is the BEST advice the regulatory affairs professional can provide to minimize the impact of this guideline on the successful registration of the new product?

The company should consult with relevant regulatory authorities to determine the potential impact on the current registration plan.
The new guideline has no impact on the current registration plan, but the company must be prepared to defend its decision.
The new guideline has no impact on the current registration plan since all relevant registration studies are almost completed.
The company should initiate the required pediatric studies immediately to avoid costly delays to the current registration plan.

Answer(s): A,D

Reveal Solution Next Question

QUESTION: 19

Company X has a patent for an anti-inflammatory drug that will expire in one year. In order to minimize the effect of the patent expiration, which is the BEST action for the company to take?

Conduct a Phase III study for a new unrelated indication of the drug.
Develop a generic version of the drug.
Develop a better brand-name drug in the same class.
Explore litigation strategy for patent infringements on the drug.

Answer(s): B

Reveal Solution Next Question

QUESTION: 20

A regulatory affairs professional is asked to review and update regulatory affairs SOPs. Which aspect of the SOP Is MOST important to consider?

Expiration date
Relevance to regulations
Revision history
Scope and level of detail

Answer(s): B

Reveal Solution Next Question

RAPS Regulatory Affairs Certification (RAC) Global Scope RAC-GS Dumps in PDF

Free RAPS RAC-GS Real Questions (page: 4)

QUESTION: 16

QUESTION: 17

QUESTION: 18

QUESTION: 19

QUESTION: 20